Table 2. Psychosocial outcomes in the study population, by sex.a .
| Total sample (N = 218) | Males (n = 101) | Females (n = 117) | p | |
|---|---|---|---|---|
| Depression at T1, PHQ-9 | 19.1%; 95% CI, 14.4-24.8 | 11.0%; 95% CI, 6.2-18.6 | 26.1%; 95% CI, 18.9-34.8 | 0.005* |
| Depression at T1, PHQ-9 | 4 [0-23] | 3 [0-22] | 5 [0-21] | 0.03** |
| Depression at T2, PHQ-9 | 15.4%; 95% CI, 11.1-20.9 | 9.3%; 95% CI, 5.0-16.7 | 20.7%; 95% CI, 14.2-29.2 | 0.02* |
| Depression at T2, PHQ-9 | 3 [0-24] | 3 [0-24] | 3 [0-24] | 0.46** |
| Anxiety at T1, GAD-7 scale | 19.1%; 95% CI, 14.4-24.8 | 12.0%; 95% CI, 7.0-19.8 | 25.2%; 95% CI, 18.2-33.9 | 0.014* |
| Anxiety at T1, GAD-7 scale | 4 [0-20] | 3 [0-20] | 6 [0-20] | 0.005** |
| Anxiety at T2, GAD-7 scale | 18.0%; 95% CI, 13.4-23.7 | 10.2%; 95% CI, 5.6-17.8 | 24.8%; 95% CI, 17.7-33.5 | 0.006* |
| Anxiety at T2, GAD-7 scale | 4 [0-20] | 3 [0-19] | 5 [0-20] | 0.06** |
| Treatment adherence, MMAS-8 High Average Low |
5.3%; 95% CI, 2.6-10.5 28.0%; 95% CI, 21.2-36.2 66.7%; 95% CI, 58.2-74.1 |
6.8%; 95% CI, 2.7-16.2 28.8%; 95% CI, 18.6-41.4 64.4%; 95% CI, 51.7-75.4 |
4.1%; 95% CI, 1.4-11.4 27.4%; 95% CI, 1.5-38.6 68.5; 95% CI, 57.1-78 |
0.54* |
| Treatment adherence, MMAS-8 | 5 [0-8] | 5 [1-8] | 5 [0-8] | 0.93** |
T1: time point 1; T2: time point 2; PHQ-9: nine-item Patient Health Questionnaire; GAD-7: seven-item Generalized Anxiety Disorder; and MMAS-8: eight-item Morisky Medication Adherence Scale. aData expressed as % or median [IQR]. *Chi-square test (p < 0.05). **Mann-Whitney test (p < 0.05).